L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle
Sarcopenia is a common complication of cirrhosis with a negative impact on posttransplant outcome, health-related quality of life (HRQOL), and patient survival. Studies in experimental animals and in patients demonstrate that ammonia is directly implicated in the pathogenesis of sarcopenia in cirrho...
Saved in:
Main Author: | Roger F. Butterworth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2019/8182195 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
by: Roger F. Butterworth, et al.
Published: (2019-03-01) -
Lipedema: diagnosis, treatment and the vicious cycle - a review of the literature
by: Justyna Głowacka, et al.
Published: (2025-02-01) -
HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
by: Kishanda Vyboh, et al.
Published: (2015-01-01) -
Social vulnerability and tuberculosis: a vicious circle
by: Nicolás Ortiz-Ruiz, et al.
Published: (2023-01-01) -
Leptospirosis, melioidosis, and rickettsioses in the vicious circle of neglect.
by: Tshokey Tshokey, et al.
Published: (2025-01-01)